GVOKE PFS
Total Payments
$1.9M
Transactions
35,108
Doctors
13,635
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $1.3M | 20,969 | 10,119 |
| 2021 | $397,183 | 11,394 | 5,767 |
| 2020 | $192,633 | 2,745 | 1,221 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $690,226 | 34,594 | 37.0% |
| Unspecified | $660,647 | 7 | 35.4% |
| Honoraria | $322,838 | 206 | 17.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $126,236 | 101 | 6.8% |
| Travel and Lodging | $40,180 | 180 | 2.2% |
| Education | $26,250 | 20 | 1.4% |
Payments by Type
General
$1.2M
35,101 transactions
Research
$660,647
7 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| XP-9164-109 | Xeris Pharmaceuticals, Inc. | $607,647 | 0 |
| HEED the Glucagon Access Program (HEED the GAP) | Xeris Pharmaceuticals, Inc. | $53,000 | 0 |
Top Doctors Receiving Payments for GVOKE PFS
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Phila, PA | $688,023 | 57 |
| , M.D | Endocrinology, Diabetes & Metabolism | Atlanta, GA | $81,955 | 123 |
| , DNP, CPNP-PC | Pediatrics | Savannah, GA | $54,309 | 117 |
| , MD,DGO | Family Medicine | Columbus, GA | $31,666 | 54 |
| , M.D.L | Endocrinology, Diabetes & Metabolism | Laurel, MD | $31,024 | 37 |
| , MD | Endocrinology, Diabetes & Metabolism | Port Charlotte, FL | $23,476 | 47 |
| , M.D | Internal Medicine | San Diego, CA | $23,375 | 14 |
| , M.D | Infectious Disease | Deerfield, IL | $22,923 | 6 |
| , MD | Pediatrics | Charlotte, NC | $19,813 | 25 |
| , M.D | Endocrinology, Diabetes & Metabolism | Mcallen, TX | $18,146 | 21 |
| , M.D | Endocrinology, Diabetes & Metabolism | Smithtown, NY | $15,744 | 28 |
| , MD | Specialist | Oklahoma City, OK | $14,554 | 94 |
| , MD | Endocrinology, Diabetes & Metabolism | Asheville, NC | $14,451 | 16 |
| , PA-C | Medical | Chandler, AZ | $14,167 | 15 |
| , N.P | Nurse Practitioner | Philadelphia, PA | $10,841 | 25 |
| , MD | Endocrinology, Diabetes & Metabolism | Newport Beach, CA | $9,766 | 20 |
| George Grunberger | — | Bloomfield Hills, MI | $9,281 | 18 |
| , MD | Endocrinology, Diabetes & Metabolism | Farmington Hills, MI | $8,600 | 30 |
| , M.D | Endocrinology, Diabetes & Metabolism | North Providence, RI | $8,440 | 11 |
| , MD | Endocrinology, Diabetes & Metabolism | Dallas, TX | $8,068 | 47 |
| , M.D | Endocrinology, Diabetes & Metabolism | Orlando, FL | $7,239 | 7 |
| , M.D | Endocrinology, Diabetes & Metabolism | Richland, WA | $5,474 | 11 |
| , MD | Endocrinology, Diabetes & Metabolism | Springdale, AR | $5,414 | 9 |
| , M.D | Endocrinology, Diabetes & Metabolism | Columbus, OH | $5,348 | 5 |
| , MD, FACE | Endocrinology, Diabetes & Metabolism | Columbus, OH | $5,188 | 8 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $1.9M
- Total Doctors 13,635
- Transactions 35,108
About GVOKE PFS
GVOKE PFS is a drug associated with $1.9M in payments to 13,635 healthcare providers, recorded across 35,108 transactions in the CMS Open Payments database. The primary manufacturer is Xeris Pharmaceuticals, Inc..
Payment data is available from 2020 to 2022. In 2022, $1.3M was paid across 20,969 transactions to 10,119 doctors.
The most common payment nature for GVOKE PFS is "Food and Beverage" ($690,226, 37.0% of total).
GVOKE PFS is associated with 2 research studies, including "XP-9164-109" ($607,647).